Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1906 1
1950 1
1953 2
1954 1
1963 1
1964 1
1965 1
1968 2
1969 2
1970 1
1971 1
1972 1
1973 4
1975 1
1976 4
1977 3
1978 1
1979 5
1980 2
1981 1
1982 1
1983 3
1984 4
1985 5
1986 2
1987 5
1988 9
1989 11
1990 5
1991 5
1992 13
1993 6
1994 9
1995 13
1996 10
1997 12
1998 14
1999 8
2000 13
2001 14
2002 17
2003 16
2004 24
2005 23
2006 24
2007 37
2008 25
2009 37
2010 37
2011 49
2012 48
2013 75
2014 73
2015 102
2016 104
2017 83
2018 81
2019 79
2020 101
2021 112
2022 133
2023 111
2024 38

Text availability

Article attribute

Article type

Publication date

Search Results

1,447 results

Results by year

Filters applied: . Clear all
Page 1
Characterizing the tumor microenvironment of metastatic ovarian cancer by single-cell transcriptomics.
Olalekan S, Xie B, Back R, Eckart H, Basu A. Olalekan S, et al. Cell Rep. 2021 May 25;35(8):109165. doi: 10.1016/j.celrep.2021.109165. Cell Rep. 2021. PMID: 34038734 Free article.
TOX-expressing resident memory CD8(+) T (CD8(+) Trm) and granulysin-expressing CD4(+) T cell clusters are enriched in the high T(inf) group. Concurrently, we find unique plasmablast and plasma B cell clusters, and finally, NR1H2(+)IRF8(+) and CD274(+) macrophage clusters, …
TOX-expressing resident memory CD8(+) T (CD8(+) Trm) and granulysin-expressing CD4(+) T cell clusters are enriched in the high T(inf) group. …
B-Cell-Based Immunotherapy: A Promising New Alternative.
Gupta SL, Khan N, Basu S, Soni V. Gupta SL, et al. Vaccines (Basel). 2022 May 31;10(6):879. doi: 10.3390/vaccines10060879. Vaccines (Basel). 2022. PMID: 35746487 Free PMC article. Review.
In this review, we shed light on the dual nature of B cells in the tumor microenvironment. Furthermore, we discussed the different factors affecting the biology and function of B cells in tumors. In the third section, we described B-cell-based immunotherapies …
In this review, we shed light on the dual nature of B cells in the tumor microenvironment. Furthermore, we discussed the different fa …
RNA exosome drives early B cell development via noncoding RNA processing mechanisms.
Laffleur B, Batista CR, Zhang W, Lim J, Yang B, Rossille D, Wu L, Estrella J, Rothschild G, Pefanis E, Basu U. Laffleur B, et al. Sci Immunol. 2022 Jun 3;7(72):eabn2738. doi: 10.1126/sciimmunol.abn2738. Epub 2022 Jun 3. Sci Immunol. 2022. PMID: 35658015 Free PMC article.
B cell development is linked to successful V(D)J recombination, allowing B cell receptor expression and ultimately antibody secretion for adaptive immunity. ...Introduction of a prearranged Igh VDJ allele partly rescued the pre-B cell population in Dis3-defic
B cell development is linked to successful V(D)J recombination, allowing B cell receptor expression and ultimately antibody se
Cytokine and reactivity profiles in SLE patients following anti-CD19 CART therapy.
Nunez D, Patel D, Volkov J, Wong S, Vorndran Z, Müller F, Aigner M, Völkl S, Mackensen A, Schett G, Basu S. Nunez D, et al. Mol Ther Methods Clin Dev. 2023 Sep 1;31:101104. doi: 10.1016/j.omtm.2023.08.023. eCollection 2023 Dec 14. Mol Ther Methods Clin Dev. 2023. PMID: 37744005 Free PMC article.
Chimeric antigen receptor (CAR) T cells targeting CD19(+) B cells have demonstrated efficacy in refractory systemic lupus erythematosus (SLE). ...Furthermore, SLE-associated antibodies dropped profoundly in five of six patients. Last, consistent with other reports of CD19 …
Chimeric antigen receptor (CAR) T cells targeting CD19(+) B cells have demonstrated efficacy in refractory systemic lupus erythematos …
Novel UiO-NH(2)-like Zr-Based MOF (Basu-DPU) as an Excellent Catalyst for Preparation of New 6H-Chromeno[4,3-b]quinolin-6-ones.
Beiranvand M, Habibi D, Khodakarami H. Beiranvand M, et al. ACS Omega. 2023 Jul 12;8(29):25924-25937. doi: 10.1021/acsomega.3c01793. eCollection 2023 Jul 25. ACS Omega. 2023. PMID: 37521649 Free PMC article.
Then, catalytic application of the prepared zirconium-based MOF was successfully explored in the synthesis of novel 6H-chromeno[4,3-b]quinolin-6-ones 4(a-l) through a one-pot three-component condensation reaction of 4-hydroxycumarine, 1-naphthylamine, and aromatic aldehyde …
Then, catalytic application of the prepared zirconium-based MOF was successfully explored in the synthesis of novel 6H-chromeno[4,3-b
Pathogenesis of Bacterial Uveitis.
Wildner G, Bansal R, Ayyadurai N, Thurau S, Basu S. Wildner G, et al. Ocul Immunol Inflamm. 2023 Sep;31(7):1396-1404. doi: 10.1080/09273948.2022.2155842. Epub 2023 Jan 9. Ocul Immunol Inflamm. 2023. PMID: 36622856 Review.
Systemic adaptive immunity is usually induced before the bacteria are localized to the inner eye, and once T and B cells have detected the pathogens behind the blood-eye barriers they elicit an acute and/or chronic inflammatory response deteriorating visual acuity that can …
Systemic adaptive immunity is usually induced before the bacteria are localized to the inner eye, and once T and B cells have detecte …
Total Synthesis of Meayamycin B.
Bressin RK, Osman S, Pohorilets I, Basu U, Koide K. Bressin RK, et al. J Org Chem. 2020 Apr 3;85(7):4637-4647. doi: 10.1021/acs.joc.9b03370. Epub 2020 Mar 23. J Org Chem. 2020. PMID: 32162521
Meayamycin B is currently the most potent modulator of the splicing factor 3b subunit 1 and used by dozens of research groups. ...We also discuss a Z-E isomerization during the alpha,beta-unsaturated amide formation. The new synthesis of meayamycin B consists of 11 …
Meayamycin B is currently the most potent modulator of the splicing factor 3b subunit 1 and used by dozens of research groups. ...We …
Regulation of AID, the B-cell genome mutator.
Keim C, Kazadi D, Rothschild G, Basu U. Keim C, et al. Genes Dev. 2013 Jan 1;27(1):1-17. doi: 10.1101/gad.200014.112. Genes Dev. 2013. PMID: 23307864 Free PMC article. Review.
The mechanisms by which B cells somatically engineer their genomes to generate the vast diversity of antibodies required to challenge the nearly infinite number of antigens that immune systems encounter are of tremendous clinical and academic interest. ...Recent discoverie …
The mechanisms by which B cells somatically engineer their genomes to generate the vast diversity of antibodies required to challenge …
Mechanical Communication at the Immunological Synapse.
Basu R, Huse M. Basu R, et al. Trends Cell Biol. 2017 Apr;27(4):241-254. doi: 10.1016/j.tcb.2016.10.005. Epub 2016 Dec 13. Trends Cell Biol. 2017. PMID: 27986534 Free PMC article. Review.
T and B lymphocytes communicate by forming immunological synapses with antigen-presenting target cells. ...
T and B lymphocytes communicate by forming immunological synapses with antigen-presenting target cells. ...
1,447 results